New publication illustrates how the different members of the Vaccine Alliance work together and bring their unique skills and competencies to our public-private partnership.

The Investment Opportunity for the 2021-2025 period highlights the Alliance’s ambition to build on its success by providing the most comprehensive package of protection yet.

The Alliance has played a key role in increasing immunisation coverage across the continent by introducing nine vaccines providing protection against 13 vaccine-preventable diseases.

The 20 year history of an Alliance that today protects half the world’s children.

In November 2018, the Gavi Board approved allocation of USD 13.5 million as funding to support a three-year multi-faceted programme to improve Yellow Fever laboratory capacity in Africa during 2019-2021. This document is the public summary of the…

The Base Demand Forecast summarises actual and forecasted volumes for eleven vaccines that Gavi supports. The volumes presented are from the demand forecast used to inform the Gavi Financial forecast.